Physicochemical Stability Study of Polymyxin B in Various Infusion Solutions for Administration to Critically Ill Patients

Abstract

Get full access to this article

View all access options for this article.

References

Cai

Lee

Kwa

AL.

Polymyxin B versus colistin: an update. Expert Rev Anti Infect Ther. 2015;13:1481-1497. doi:10.1586/14787210.2015.1093933.

Figueroa

Lim

Chow

Tam

VH.

Stability of polymyxin B sulfate diluted in 0.9% sodium chloride injection and stored at 4 or 25 degrees C. Am J Health Syst Pharm. 2010;67:1191-1194. doi:10.2146/ajhp090472.

Ledesma

Lam

. Variability of polymyxin B major components in commercial formulations. Int J Antimicrob Agents. 2010;35:308-310. doi:10.1016/j.ijantimicag.2009.11.005.

Plachouras

Karvanen

Friberg

. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria. Antimicrob Agents Chemother. 2009;53:3430-3436. doi:10.1128/AAC.01361-08.

Akajagbor

Wilson

Shere-Wolfe

Dakum

Charurat

Gilliam

BL.

Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center. Clin Infect Dis. 2013;57:1300-1303. doi:10.1093/cid/cit453.